Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes

Diabetic Medicine

Volumn 26, Issue 7, 2009, Pages 665-672

  Choudhary, P ^b   Lonnen, K ^c   Emery, C J ^a   MacDonald, I A ^d   MacLeod, K M ^c   Amiel, S A ^b   Heller, S R ^a,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PENINSULA MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cognitive function; Hypoglycaemia; Sulphonylureas; Symptoms; Type 2 diabetes

Indexed keywords

ADRENALIN; C PEPTIDE; GLICLAZIDE; GLUCAGON; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; METFORMIN; NORADRENALIN; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART RATE; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL ANALYSIS; SYMPTOM;

AGED; BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; COGNITION; DIABETES MELLITUS, TYPE 2; EPINEPHRINE; FASTING; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MIDDLE AGED; NOREPINEPHRINE; SULFONYLUREA COMPOUNDS; TREMOR;

EID: 67649774240     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02759.x     Document Type: Article

References (34)

1. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia 2002 45 : 937 948. (Pubitemid 34762188)
2. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 1991 260 : E67 E74.
3. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995 18 : 517 522.
4. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994 17 : 697 703. (Pubitemid 24198035)
5. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997 20 : 135 141. (Pubitemid 27051549)
6. Meneilly GS, Cheung E, Tuokko H. Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrinol Metab 1994 78 : 1341 1348. (Pubitemid 24181002)
7. Spyer G, Hattersley AT, MacDonald IA, Amiel S, MacLeod KM. Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well-controlled type 2 diabetes. Lancet 2000 356 : 1970 1974.
8. Levy CJ, Kinsley BT, Bajaj M, Simonson DC. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM. Diabetes Care 1998 21 : 1330 1338. (Pubitemid 28365693)
9. Korzon-Burakowska A, Hopkins D, Matyka K, Lomas J, Pernet A, Macdonald I et al. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes. Diabetes Care 1998 21 : 283 290. (Pubitemid 28079439)
10. Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002 51 : 724 733. (Pubitemid 34760182)
11. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987 316 : 1376 1383. (Pubitemid 17079681)
12. Bingham E, Hopkins D, Pernet A, Reid H, MacDonald IA, Amiel SA. The effects of KATP channel modulators on counterregulatory responses and cognitive function during acute controlled hypoglycaemia in healthy men: a pilot study. Diabet Med 2003 20 : 231 237. (Pubitemid 36390740)
13. UK Hypoglycemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007 50 : 1140 1147.
14. Liu D, Moberg E, Kollind M, Lins PE, Adamson U, MacDonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992 35 : 287 290.
15. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 1993 36 : 771 777. (Pubitemid 23218647)
16. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet Med 2001 18 : 690 705. (Pubitemid 32955520)
17. Bench CJ, Frith CD, Grasby PM, Friston KJ, Paulesu E, Frackowiak RS et al. Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia 1993 31 : 907 922. (Pubitemid 23283776)
18. Wechsler D. Manual for the Wechsler Adult Intelligence Scale-Revised. New York : Psychological Corp., 1981.
19. Forster CD, MacDonald IA. The assay of the catecholamine content of small volumes of human plasma. Biomed Chromatogr 1999 13 : 209 215. (Pubitemid 29248375)
20. DCCT. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group. Clin Chem 1987 33 : 2267 2271.
21. Evans ML, Hopkins D, MacDonald IA, Amiel SA. Alanine infusion during hypoglycaemia partly supports cognitive performance in healthy human subjects. Diabet Med 2004 21 : 440 446. (Pubitemid 38608531)
22. George E, Harris N, Bedford C, MacDonald IA, Hardisty CA, Heller SR. Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycaemia in normal subjects. Diabetologia 1995 38 : 1183 1190.
23. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 1991 40 : 223 226.
24. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994 43 : 1426 1434.
25. McGowan K, Thomas W, Moran A. Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002 25 : 1499 1503. (Pubitemid 41071101)
26. Choudhary P, Davies C, Emery C, Freeman J, Heller SR. Low interstitial glucose detected by CGMS correlates well with clinically significant hypoglycaemia. Diabet Med 2006 23 : 12.
27. Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B. Reproducibility and reliability of hypoglycaemic episodes recorded with continuous glucose monitoring system (CGMS) in daily life. Diabet Med 2005 22 : 858 862. (Pubitemid 40942582)
28. Gandrud LM, Xing D, Kollman C, Block JM, Kunselman B, Wilson DM et al. The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age. Diabetes Technol Ther 2007 9 : 307 316. (Pubitemid 47340081)
29. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W et al. Frequency of severe hypoglycaemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003 26 : 1176 1180. (Pubitemid 36929268)
30. Kobayashi K, Kimura M, Sakoguchi T, Hase A, Matsuoka A. Pharmoacokinetics of glicazide in healthy and diabetic subjects. J Pharm Sci 1984 73 : 1684 1687. (Pubitemid 15190911)
31. Israelian Z, Szoke E, Woerle J, Bokhari S, Schorr M, Schwenke DC et al. Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus. Metabolism 2006 55 : 593 598.
32. Evans ML, McCrimmon RJ, Flanagan DE, Keshavarz T, Fan X, McNay EC et al. Hypothalamic ATP-sensitive K+ channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes 2004 53 : 2542 2551. (Pubitemid 39299260)
33. Routh VH. Glucosensing neurons in the ventromedial hypothalamic nucleus (VMN) and hypoglycemia-associated autonomic failure (HAAF). Diabetes Metab Res Rev 2003 19 : 348 356. (Pubitemid 37185375)
34. Babenko AP, Guilar-Bryan L, Bryan J. A view of sur/KIR6.X, KATP channels. Annu Rev Physiol 1998 60 : 667 687. (Pubitemid 28157891)